SBIR/STTR Research Award
IMMUNOISOLATED CELL TRANSPLANTS FOR TREATMENT OF PARKINSON'S DISEASE
Award amount
$50,000Program and phase
SBIR · Phase IAward year
1990Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- Not reported
- Recipient company
- Cellular Transplants Inc
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
STRIATAL TRANSPLANTATION OF NEUROTRANSMITTER CELLS, IMMUNOISOLATED WITHIN A PERMSELECTIVE POLYMER MEMBRANE CAPSULE, REPRESENTS A NOVEL APPROACH TO THE TREATMENT OF PARKINSON'S DISEASE. THE TECHNIQUE HAS HAD PROMISING RESULTS IN SEVERAL RODENT MODELS, AND PRIMATE STUDIES ARE UNDERWAY. THE OVERALL OBJECTIVE OF THIS RESEARCH IS TO COMPLETE THE DEVELOPMENTS NECESSARY FOR WIDESPREAD MEDICAL ACCEPTANCE OF IMMUNOISOLATED CELLULAR TRANSPLANTATION IN THE TREATMENT OF NEURAL DISEASES. ONE UNACHIEVED PREREQUISITE TO SUCH ACCEPTANCE IS UNEQUIVOCAL DEMONSTRATION OF CAPSULE INTEGRITY AND COMPLETE SEGREGATION OF THE FOREIGN MATERIAL FROM THE HOST. ACCORDINGLY, THE SPECIFIC OBJECTIVE OF THIS PROJECT IS TO DEVELOP AND VALIDATE AN IN VIVO ASSAY OF INDIVIDUAL CAPSULE INTEGRITY BASED UPON ANTIBODY-MEDIATED COMPLEMENT LYSIS OF ENCAPSULATED PC12 CELLS.
Technology keywords
Not reported